Tumor Infiltrating Lymphocyte

BIOLOGICAL3 trials

Sponsors

CAR-T (Shanghai) Cell Biotechnology Co., Ltd., Shanghai Juncell Therapeutics

Conditions

Advanced Liver CancersAdvanced MelanomaAdvanced Pancreatic CancersEffects of ImmunotherapyHepatic CarcinomaTreatment Side EffectsTumor Infiltrating Lymphocyte

Early Phase 1

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

RecruitingNCT05098197

Shanghai Juncell TherapeuticsAdvanced Liver Cancers, Advanced Pancreatic Cancers, Effects of Immunotherapy +2

Start: 2021-09-26End: 2026-09-25Target: 50Updated: 2025-12-11

A Study of GC101 TIL in Advanced Melanoma (10hospital)

RecruitingNCT05098184

Shanghai Juncell TherapeuticsAdvanced Melanoma, Effects of Immunotherapy, Treatment Side Effects +1

Start: 2021-09-26End: 2026-09-25Target: 50Updated: 2025-12-11

Phase 1

A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs

CAR-T (Shanghai) Cell Biotechnology Co., Ltd.Hepatic Carcinoma

Start: 2020-08-26End: 2022-10-31Target: 40Updated: 2020-09-04